Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights.
Saved in:
| Title: | Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights. |
|---|---|
| Authors: | Ganelin-Cohen E; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Neuroimmunological Clinic, Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel., Wexler Y; The George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel., Kraus S; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Neuroimmunological Clinic, Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel., Rozenberg A; The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.; Department of Neurology, Rambam Health Care Campus, Haifa, Israel. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1727925. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1727925 |
